These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 6282033)
21. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma. Samojlik E; Veldhuis JD; Wells SA; Santen RJ J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409 [TBL] [Abstract][Full Text] [Related]
22. [Influence of the oral adminsitration of estrogens on serum gonadotropins and prolactin after the menopause]. Delvoye P; Vekemans M; Calaf J; L'Hermite M; Robyn C J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):357-9. PubMed ID: 4681545 [No Abstract] [Full Text] [Related]
23. [The effect of carbon disulphide on menopause, concentration of monoamines, gonadotropins, estrogens and androgens in women]. Pieleszek A Ann Acad Med Stetin; 1997; 43():255-67. PubMed ID: 9471921 [TBL] [Abstract][Full Text] [Related]
24. Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations. Kaider AS; Coulam CB Early Pregnancy (Cherry Hill); 2000 Jul; 4(3):191-9. PubMed ID: 11727011 [TBL] [Abstract][Full Text] [Related]
25. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer. De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871 [TBL] [Abstract][Full Text] [Related]
26. A comparative study of the estrogenic effects of tamoxifen and 17 beta-estradiol in postmenopausal women. Helgason S; Wilking N; Carlström K; Damber MG; von Schoultz B J Clin Endocrinol Metab; 1982 Feb; 54(2):404-8. PubMed ID: 6798066 [TBL] [Abstract][Full Text] [Related]
27. Endocrine studies in postmenopausal women during oral replacement therapy with unconjugated oestrogens. Vasquez JM; Samaras CA; Nezhat C Reproduccion; 1982; 6(2):49-59. PubMed ID: 6216132 [TBL] [Abstract][Full Text] [Related]
28. Clinical and endocrine studies in menopausal women after estradiol pellet implantation. Nagamani M; Lin TJ; McDonough PG; Watatani H; McPherson JC; Mahesh VB Obstet Gynecol; 1977 Nov; 50(5):541-7. PubMed ID: 909658 [TBL] [Abstract][Full Text] [Related]
29. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer. Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689 [TBL] [Abstract][Full Text] [Related]
30. Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients. Wilking N; Carlström K; Sköldefors H; Theve NO; Wallgren A Acta Chir Scand; 1982; 148(4):345-9. PubMed ID: 6215811 [TBL] [Abstract][Full Text] [Related]
31. Gonadotropins and prolactin during estrogen replacement therapy. Helgason S; Carlström K; Damber MG; von Schoultz B Acta Obstet Gynecol Scand; 1981; 60(5):515-6. PubMed ID: 6795895 [No Abstract] [Full Text] [Related]
32. Regional adipose tissue metabolism in postmenopausal women after treatment with exogenous sex steroids. Lindberg UB; Crona N; Silfverstolpe G; Björntorp P; Rebuffé-Scrive M Horm Metab Res; 1990 Jun; 22(6):345-51. PubMed ID: 2116375 [TBL] [Abstract][Full Text] [Related]
33. Effects of an antiestrogen on subfractions of HDL cholesterol during estrogen replacement therapy. Ottosson UB; Carlström K; Johansson BG; von Schoultz B Gynecol Obstet Invest; 1984; 18(3):140-6. PubMed ID: 6436151 [TBL] [Abstract][Full Text] [Related]
34. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131 [TBL] [Abstract][Full Text] [Related]
35. Suppression of prolactin and gonadotropin secretion in post-menopausal women by 2-hydroxyestrone. Schinfeld JS; Tulchinsky D; Schiff I; Fishman J J Clin Endocrinol Metab; 1980 Feb; 50(2):408-10. PubMed ID: 7354124 [TBL] [Abstract][Full Text] [Related]
36. A new and sensitive method for quantifying and comparing the biological potency of varius estrogens in man. Damber MG; Sandström B; von Schoultz B; Stigbrand T Acta Obstet Gynecol Scand; 1979; 58(6):527-30. PubMed ID: 550692 [TBL] [Abstract][Full Text] [Related]
37. The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin. Andersen JR; Schroeder E; Lebech PE Acta Endocrinol (Copenh); 1980 Dec; 95(4):433-7. PubMed ID: 6779473 [TBL] [Abstract][Full Text] [Related]
38. Estrogenic activities of estradiol enantate and ethinylestradiol compared at a clinical level. Moguilevsky JA; Wiemeyer JC; Sagasta CL; Leiderman S Arzneimittelforschung; 1986 Nov; 36(11):1671-4. PubMed ID: 3101711 [TBL] [Abstract][Full Text] [Related]
39. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. Elger W; Schwarz S; Hedden A; Reddersen G; Schneider B J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):395-403. PubMed ID: 8541236 [TBL] [Abstract][Full Text] [Related]
40. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Kelly JJ; Rajkovic IA; O'Sullivan AJ; Sernia C; Ho KK Clin Endocrinol (Oxf); 1993 Nov; 39(5):561-7. PubMed ID: 8252746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]